Oncology Institute Cash Flow Statement (2020-2026) | DFPH

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-2.98M-10.16M19.29M-5.45M-2.67M-11.01M-30.00M-16.90M-17.42M-18.75M-19.89M-15.48M-16.11M-13.18M-19.59M-17.01M-16.50M-7.51M-2.49M-9.79M
Depreciation and Depletion (Quarter)
0.23M0.26M0.31M0.36M0.39M0.46M0.54M0.60M0.91M0.81M0.71M0.74M0.80M0.93M1.01M1.03M1.01M0.92M0.90M1.12M
Share-based Compensation (Quarter)
0.15M24.38M8.55M6.51M6.55M-21.20M4.96M4.11M4.66M4.08M4.09M3.39M2.39M1.29M1.46M0.75M1.02M1.32M1.69M1.07M
Deferred Taxes (Quarter)
-3.76M2.30M0.18M-0.05M0.05M-0.45M-0.03M-0.00M0.08M-0.13M
Gains from Investment Securities (Quarter)
-3.69M1.46M-2.06M0.16M-58.77M-0.75M-0.02M-0.02M1.08M-0.55M-0.02M-0.05M0.04M0.05M0.15M0.00M-0.17M-0.01M
Asset Writedowns and Impairment (Quarter)
0.06M0.25M0.15M0.10M0.14M0.07M0.00M-0.00M0.03M1.99M
Cash from Operations (Quarter)
-2.68M-23.34M-16.98M-10.38M-20.40M-14.00M-15.45M-8.66M-8.31M-3.89M-15.88M-15.66M0.82M4.00M-4.99M-10.20M-12.63M3.23M-2.21M11.94M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
9.94M16.87M
Amortizatization of Intangibles (Quarter)
0.03M0.99M0.92M0.67M-0.88M1.92M0.32M0.13M0.05M0.00M
Amortization of Deferred Charges (Quarter)
0.02M0.89M1.55M1.52M1.54M1.57M1.57M1.56M1.56M1.59M1.59M4.87M1.13M1.17M1.21M1.21M1.26M
Depreciation & Amortization (CF) (Quarter)
0.85M0.92M0.99M1.10M1.13M1.19M1.27M1.33M1.70M1.58M1.49M1.52M1.57M1.71M1.78M1.80M1.72M1.63M1.62M1.84M
Change in Working Capital
Change in Receivables (Quarter)
2.40M-2.00M4.66M4.54M6.01M5.07M6.14M0.43M2.08M-4.09M16.40M-4.74M0.48M-6.17M0.98M7.98M3.98M-0.64M-0.86M8.21M
Change in Inventory (Quarter)
1.07M0.50M1.33M0.40M0.85M-0.85M0.99M1.91M0.01M1.47M-2.12M-0.23M-1.22M-0.07M2.27M3.48M3.10M-2.01M7.42M-4.28M
Change in Account Payables (Quarter)
5.30M-3.33M-2.96M1.30M-2.75M-1.78M2.57M1.18M0.21M1.10M6.36M-5.46M7.58M0.74M5.06M6.43M0.44M7.71M4.61M12.50M
Change in Accured Expenses (Quarter)
-0.06M-4.52M0.53M2.04M0.33M-0.55M-0.81M2.15M-0.77M2.78M5.37M-3.39M2.84M4.66M2.57M-0.30M0.13M-2.84M3.92M3.44M
Change in Taxes (Quarter)
4.38M-6.03M0.26M-0.13M-0.00M-0.26M
Other Working Capital Changes (Quarter)
3.01M-8.90M
Investing Activities
Capital Expenditures (Quarter)
0.95M0.87M1.00M1.34M-2.20M5.39M1.84M-1.76M0.00M0.00M0.61M-0.59M0.01M3.76M0.00M1.53M-1.54M3.20M0.01M0.91M
Sales of Property, Plant and Equipment (Quarter)
0.13M
Acquisitions (Quarter)
8.28M8.92M-0.81M0.47M0.16M
Change in Acquisitions & Divestments (Quarter)
30.00M30.13M8.57M12.56M20.00M20.00M10.00M
Cash from Investing Activities (Quarter)
-0.95M-9.15M-1.00M-10.26M-87.78M-32.57M18.40M24.90M7.71M11.63M19.39M18.18M10.40M-1.75M-0.20M-1.21M-0.60M-1.06M-1.04M-0.91M
Financing Activities
Other financing activities (Quarter)
0.14M15.22M-12.66M12.66M0.02M0.09M
Cash from Financing Activities (Quarter)
-0.01M136.13M-1.66M-10.69M105.39M-0.85M-1.71M-2.60M-0.76M-1.78M-0.94M-2.15M-0.24M-0.16M-4.74M1.96M10.60M3.73M-0.03M-0.22M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
0.08M0.01M0.11M0.07M0.00M-0.07M0.14M2.20M7.00M3.89M
Additional items
Change in Cash (Quarter)
-3.64M103.64M-19.64M-31.33M-2.78M-47.41M1.24M13.64M-1.36M5.95M2.57M0.37M10.98M2.27M-9.93M-9.45M-2.63M5.91M-3.29M10.81M
Free Cash Flow (Quarter)
-3.63M-24.21M-17.98M-11.72M-18.20M-19.39M-17.29M-6.90M-8.31M-3.89M-16.49M-15.07M0.81M0.24M-4.99M-11.74M-11.09M0.03M-2.23M11.03M
Net Cash Flow (Quarter)
-3.64M103.64M-19.64M-31.33M-2.78M-47.41M1.24M13.64M-1.36M5.95M2.57M0.37M10.98M2.08M-9.93M-9.45M-2.63M5.91M-3.29M10.81M